Metabolic reprogramming by PRDM16 drives cytarabine resistance in acute myeloid leukemia

被引：0

作者：

Ikeda, Junji ^{[1
,2
]}

Kunimoto, Hiroyoshi ^{[2
]}

Saito, Yusuke ^{[3
]}

Tsujimoto, Shinichi ^{[1
]}

Murakami, Koichi ^{[4
]}

Kato, Ikuma ^{[5
]}

Hishiki, Takako ^{[6
]}

Hayakawa, Noriyo ^{[6
,7
]}

Matsuura, Tomomi ^{[6
,7
]}

Tago, Megumi ^{[8
]}

Yokoyama, Akihiko ^{[9
]}

Tomizawa, Daisuke ^{[10
]}

Adachi, Souichi ^{[11
]}

Shiba, Norio ^{[1
]}

Tamura, Tomohiko ^{[4
]}

Nakajima, Hideaki ^{[2
]}

机构：

[1] Yokohama City Univ, Dept Pediat, Yokohama, Kanagawa, Japan

[2] Yokohama City Univ, Dept Stem Cell & Immune Regulat, Yokohama, Kanagawa, Japan

[3] Hokkaido Univ Hosp, Div Clin Canc Genom, Sapporo, Hokkaido, Japan

[4] Yokohama City Univ, Dept Immunol, Yokohama, Kanagawa, Japan

[5] Yokohama City Univ, Dept Mol Path, Yokohama, Kanagawa, Japan

[6] Keio Univ, Dept Biochem, Sch Med, Keio, Japan

[7] Keio Univ, Clin & Translat Res Ctr, Sch Med, Keio, Japan

[8] Keio Univ, Div Hygien Chem, Fac Pharm, Keio, Japan

[9] Tsuruoka Metabol Lab, Natl Canc Ctr, Tsuruoka, Yamagata, Japan

[10] Childrens Canc Ctr, Natl Ctr Child Hlth & Dev, Tokyo, Japan

[11] Kyoto Univ, Dept Human Hlth Sci, Kyoto, Japan

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

E-3022

引用

页码：1355 / 1355

页数：1